James Cassella V.

Companies

• Trevi Therapeutics, Inc.Chief Development Officer Oct 1, 2024 to now¹
• Trevi Therapeutics, Inc.Board member Feb 18, 2020 to Jun 14, 2024²
• CONCERT PHARMACEUTICALS, INC.Chief Development Officer Feb 4, 2015 to Mar 6, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CPCONCERT PHARMACEUTICALS, INC.0 shares⁴Mar 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 6, 2023Returned to company 57,766 shares of CONCERT PHARMACEUTICALS, INC.⁴
• Mar 6, 2023U 80,595 shares of CONCERT PHARMACEUTICALS, INC.⁴
• Feb 15, 2023Sold 3,762 shares at $8.34 of CONCERT PHARMACEUTICALS, INC.⁵
• Jan 30, 2023Sold 10,106 shares at $8.35 of CONCERT PHARMACEUTICALS, INC.⁶
• Jan 6, 2023Sold 2,893 shares at $7.25 of CONCERT PHARMACEUTICALS, INC.⁷
• Feb 14, 2022Sold 3,762 shares at $3.09 of CONCERT PHARMACEUTICALS, INC.⁸
• Jan 28, 2022Granted 34,700 shares of CONCERT PHARMACEUTICALS, INC.⁹
• Jan 28, 2022Granted 75,800 shares of CONCERT PHARMACEUTICALS, INC.⁹
• Jan 5, 2022Sold 2,894 shares at $3.19 of CONCERT PHARMACEUTICALS, INC.¹⁰